» Articles » PMID: 33237337

Autonomic Nervous System Activity and the Risk of Nosocomial Infection in Critically Ill Patients with Brain Injury

Overview
Specialty Critical Care
Date 2020 Nov 25
PMID 33237337
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Nosocomial infection contributes to adverse outcome after brain injury. This study investigates whether autonomic nervous system activity is associated with a decreased host immune response in patients following stroke or traumatic brain injury (TBI).

Methods: A prospective study was performed in adult patients with TBI or stroke who were admitted to the Intensive Care Unit of our tertiary university hospital between 2013 and 2016. Heart rate variability (HRV) was recorded daily and assessed for autonomic nervous system activity. Outcomes were nosocomial infections and immunosuppression, which was assessed ex vivo using whole blood stimulations with plasma of patients with infections, matched non-infected patients and healthy controls.

Results: Out of 64 brain injured patients, 23 (36%) developed an infection during their hospital stay. The ability of brain injured patients to generate a host response to the bacterial endotoxin lipopolysaccharides (LPS) was diminished compared to healthy controls (p < 0.001). Patients who developed an infection yielded significantly lower TNF-α values (86 vs 192 pg/mL, p = 0.030) and a trend towards higher IL-10 values (122 vs 84 pg/mL, p = 0.071) following ex vivo whole blood stimulations when compared to patients not developing an infection. This decreased host immune response was associated with altered admission HRV values. Brain injured patients who developed an infection showed increased normalized high-frequency power compared to patients not developing an infection (0.54 vs 0.36, p = 0.033), whereas normalized low-frequency power was lower in infected patients (0.46 vs 0.64, p = 0.033).

Conclusion: Brain injured patients developing a nosocomial infection show parasympathetic predominance in the acute phase following brain injury, reflected by alterations in HRV, which parallels a decreased ability to generate an immune response to stimulation with LPS.

Citing Articles

Long COVID and the Autonomic Nervous System: The Journey from Dysautonomia to Therapeutic Neuro-Modulation through the Retrospective Analysis of 152 Patients.

Colombo J, Weintraub M, Munoz R, Verma A, Ahmad G, Kaczmarski K NeuroSci. 2024; 3(2):300-310.

PMID: 39483361 PMC: 11523758. DOI: 10.3390/neurosci3020021.


Hospital-acquired infections as a risk factor for post-traumatic epilepsy: A registry-based cohort study.

Chen Z, Laing J, Li J, OBrien T, Gabbe B, Semple B Epilepsia Open. 2024; 9(4):1333-1344.

PMID: 38727134 PMC: 11296124. DOI: 10.1002/epi4.12957.


Bi-directional neuro-immune dysfunction after chronic experimental brain injury.

Ritzel R, Li Y, Jiao Y, Doran S, Khan N, Henry R J Neuroinflammation. 2024; 21(1):83.

PMID: 38581043 PMC: 10996305. DOI: 10.1186/s12974-024-03082-y.


The brain-bone marrow axis and its implications for chronic traumatic brain injury.

Ritzel R, Li Y, Jiao Y, Doran S, Khan N, Henry R Res Sq. 2023; .

PMID: 37790560 PMC: 10543403. DOI: 10.21203/rs.3.rs-3356007/v1.


Heart rate variability as a predictor of stroke course, functional outcome, and medical complications: A systematic review.

Aftyka J, Staszewski J, Debiec A, Pogoda-Wesolowska A, Zebrowski J Front Physiol. 2023; 14:1115164.

PMID: 36846317 PMC: 9947292. DOI: 10.3389/fphys.2023.1115164.


References
1.
Chen Z, Tang L, Xu X, Wei X, Wen L, Xie Q . Therapeutic effect of beta-blocker in patients with traumatic brain injury: A systematic review and meta-analysis. J Crit Care. 2017; 41:240-246. DOI: 10.1016/j.jcrc.2017.05.035. View

2.
Aboab J, Mayaud L, Sebille V, de Oliveira R, Jourdain M, Annane D . Esmolol indirectly stimulates vagal nerve activity in endotoxemic pigs. Intensive Care Med Exp. 2018; 6(1):14. PMC: 6031554. DOI: 10.1186/s40635-018-0178-1. View

3.
Shim R, Wong C . Ischemia, Immunosuppression and Infection--Tackling the Predicaments of Post-Stroke Complications. Int J Mol Sci. 2016; 17(1). PMC: 4730309. DOI: 10.3390/ijms17010064. View

4.
Sykora M, Siarnik P, Diedler J . β-Blockers, Pneumonia, and Outcome After Ischemic Stroke: Evidence From Virtual International Stroke Trials Archive. Stroke. 2015; 46(5):1269-74. DOI: 10.1161/STROKEAHA.114.008260. View

5.
Buchman T, Stein P, Goldstein B . Heart rate variability in critical illness and critical care. Curr Opin Crit Care. 2002; 8(4):311-5. DOI: 10.1097/00075198-200208000-00007. View